Narmada Gelatines Past Earnings Performance
Past criteria checks 2/6
Narmada Gelatines has been growing earnings at an average annual rate of 7.7%, while the Chemicals industry saw earnings growing at 14.5% annually. Revenues have been growing at an average rate of 9.2% per year. Narmada Gelatines's return on equity is 14.6%, and it has net margins of 8.6%.
Key information
7.7%
Earnings growth rate
7.7%
EPS growth rate
| Chemicals Industry Growth | 17.7% |
| Revenue growth rate | 9.2% |
| Return on equity | 14.6% |
| Net Margin | 8.6% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Narmada Gelatines makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 1,877 | 161 | 157 | 0 |
| 30 Jun 24 | 1,847 | 157 | 154 | 0 |
| 31 Mar 24 | 1,818 | 153 | 151 | 0 |
| 31 Dec 23 | 1,822 | 150 | 149 | 0 |
| 30 Sep 23 | 1,867 | 173 | 146 | 0 |
| 30 Jun 23 | 1,905 | 166 | 143 | 0 |
| 31 Mar 23 | 1,911 | 153 | 139 | 0 |
| 31 Dec 22 | 1,825 | 142 | 134 | 0 |
| 30 Sep 22 | 1,744 | 129 | 131 | 0 |
| 30 Jun 22 | 1,632 | 113 | 126 | 0 |
| 31 Mar 22 | 1,574 | 123 | 124 | 0 |
| 31 Dec 21 | 1,562 | 106 | 124 | 0 |
| 30 Sep 21 | 1,510 | 80 | 123 | 0 |
| 30 Jun 21 | 1,464 | 83 | 119 | 0 |
| 31 Mar 21 | 1,349 | 85 | 117 | 0 |
| 31 Dec 20 | 1,291 | 95 | 117 | 0 |
| 30 Sep 20 | 1,232 | 97 | 115 | 0 |
| 30 Jun 20 | 1,257 | 126 | 115 | 0 |
| 31 Mar 20 | 1,343 | 129 | 116 | 0 |
| 31 Dec 19 | 1,337 | 140 | 113 | 0 |
| 30 Sep 19 | 1,352 | 157 | 116 | 0 |
| 30 Jun 19 | 1,288 | 124 | 113 | 0 |
| 31 Mar 19 | 1,258 | 101 | 111 | 0 |
| 31 Dec 18 | 1,218 | 81 | 107 | 0 |
| 30 Sep 18 | 1,180 | 72 | 104 | 0 |
| 30 Jun 18 | 1,205 | 62 | 101 | 0 |
| 31 Mar 18 | 1,177 | 80 | 101 | 0 |
| 31 Dec 17 | 1,168 | 90 | 101 | 0 |
| 30 Sep 17 | 1,150 | 66 | 101 | 0 |
| 30 Jun 17 | 1,136 | 56 | 100 | 0 |
| 31 Mar 17 | 1,129 | 61 | 102 | 0 |
| 31 Dec 16 | 1,162 | 43 | 100 | 0 |
| 30 Sep 16 | 1,224 | 61 | 104 | 0 |
| 30 Jun 16 | 1,274 | 72 | 107 | 0 |
| 31 Mar 16 | 1,315 | 83 | 109 | 0 |
| 31 Dec 15 | 1,337 | 108 | 141 | 1 |
| 30 Sep 15 | 1,344 | 125 | 138 | 1 |
| 30 Jun 15 | 1,320 | 135 | 136 | 1 |
| 31 Mar 15 | 1,343 | 155 | 109 | 0 |
| 31 Dec 14 | 1,331 | 151 | 130 | 1 |
| 30 Sep 14 | 1,339 | 156 | 130 | 1 |
| 30 Jun 14 | 1,339 | 162 | 129 | 1 |
| 31 Mar 14 | 1,305 | 163 | 127 | 1 |
| 31 Dec 13 | 1,280 | 169 | 119 | 2 |
Quality Earnings: 526739 has high quality earnings.
Growing Profit Margin: 526739's current net profit margins (8.6%) are lower than last year (9.2%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 526739's earnings have grown by 7.7% per year over the past 5 years.
Accelerating Growth: 526739's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 526739 had negative earnings growth (-6.5%) over the past year, making it difficult to compare to the Chemicals industry average (7.3%).
Return on Equity
High ROE: 526739's Return on Equity (14.6%) is considered low.